Introduction {#Sec1}
============

The left atrium (LA) and right atrium (RA) are not only reservoirs, but also have active emptying functions that contribute 15--30% of ventricular filling^[@CR1],\ [@CR2]^. LA impairment increases with age^[@CR3],\ [@CR4]^, and in diseases such as hypertension^[@CR5]^, heart failure^[@CR6]^, atrial fibrillation^[@CR7]^, hypertrophic cardiomyopathy^[@CR8]^, and amyloidosis^[@CR9]^. In addition, LA enlargement and LA functional changes are associated with cardiovascular mortality or worse prognosis in patients with atrial fibrillation^[@CR10],\ [@CR11]^, non-ischemic dilated cardiomyopathy^[@CR12]^, hypertrophic cardiomyopathy^[@CR13]^, and in the general population with different cardiovascular risks^[@CR14]^. Compared with the LA, the RA is less studied^[@CR2],\ [@CR15]^, although RA function is related to the severity and prognosis of pulmonary hypertension and congenital heart disease^[@CR16],\ [@CR17]^.

Traditionally, two-dimensional (2D) echocardiography has been used to evaluate LA dimension and size, and the newer three-dimensional (3D) echocardiography has improved the accuracy of measurement of the atrial volume. Cardiovascular magnetic resonance imaging (CMR) has advantages in the evaluation of atrial size and phasic function compared with echocardiography and cardiac computed tomography (CT)^[@CR1],\ [@CR18],\ [@CR19]^. CMR can provide accurate measurements of dimension, volume, and structure of the atria, with high temporal and spatial resolution. Cardiac CT also has high spatial resolution; however, radiation and nephrotoxic contrast limit its widespread use in repeated measurements. CMR is the gold standard to evaluate ventricular volumes and should also be the standard for atrial volume assessment. Accurate normal atrial reference values are crucial in clinical practice and research. Maceria *et al*. published normal atrial reference values derived from subjects of European descent^[@CR20],\ [@CR21]^. Similar data is not available for the Chinese population. Therefore, we aimed to provide the normal reference values for the Chinese population and study the impact of gender and age on atrial size and function.

Materials and Methods {#Sec2}
=====================

Subjects {#Sec3}
--------

Healthy volunteers (n = 135) were recruited into this prospective study. All subjects provided a detailed history, and received a physical examination, a 12-lead electrocardiography, blood pressure measurement, and blood tests (including complete blood count), liver and renal function tests, and transthoracic echocardiography screening. The exclusion criteria were as follows: any known cardiovascular disease, hypertension, cerebrovascular disease or nervous system disease, chronic lung disease, diabetes, cancer, autoimmune diseases, recent systemic infection (within a month), recent surgery or severe trauma (within a month), any recent medications, and a history of implantation of pacemaker or other metals that are a contraindication for CMR. Subjects with abnormal findings on the comprehensive examination were also excluded. This study was approved by the ethics committee of West China Hospital, and all methods were performed in accordance with the approved guidelines. All subjects gave written informed consent.

Cardiac Magnetic Resonance Imaging {#Sec4}
----------------------------------

Image acquisition was performed with a 3.0-T MRI scanner (Magnetom Tim Trio; Siemens Medical Solutions, Erlangen, Germany) using a 4-channel phased-array receiver coil combined with a spine coil. Images were acquired by steady-state free precession (SSFP) sequence during breath-holds with retrospective electrocardiogram (ECG) gating (TR, 3.4 ms; TE, 1.3 ms; flip angle, 50 degrees; FOV, 320--340 mm; matrix size, 256 × 144; and slice thickness 6 mm, with no gap). Temporal resolution was 42 ms and reconstruction in plane spatial resolution was 1.4 mm \* 1.3 mm. Atrial images were acquired in consecutive short-axis views from the atria-ventricular ring to the base of the atria and in long-axis views (2-, 3-, and 4-chamber (ch)). Right ventricle (RV) 2-ch slice was performed to evaluate the RA.

Image Analysis {#Sec5}
--------------

### LA Measurement {#Sec6}

All CMR images were measured using a dedicated CMR post-processing software (Qmass 7.6, Medis, The Netherlands). LA dimensions were measured at the end of the systolic phase of the left ventricle (before the opening of the mitral valve) on 2-ch, 3-ch, and 4-ch SSFP cine images (Fig. [1](#Fig1){ref-type="fig"}). The LA volume was measured by two methods. First, the bi-plane area-length method with manually drawn endocardial contours in 2-and 4-ch views with exclusion of left atrial appendage and pulmonary veins^[@CR22]--[@CR25]^; and second, the short axis (SAX) method using Simpson's method on the short axis slices of the atria. To calculate the atrial stoke volume and empty fraction (EF), the atrial volume at three phases during the cardiac cycle was measured. LA maximal volume (LAV~max~) was defined at the end systole before the opening of the mitral valve. LA minimal volume (LAV~min~) was defined at the end of diastole, just before the closure of the mitral valve. The pre-atrial contraction volume (LAV~p−ac~) was defined at the beginning of left atrial active contraction phase at the mid diastole of the ventricle. Parameters for atrial emptying volume and emptying function were calculated as follows:$$\documentclass[12pt]{minimal}
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The indexed dimension and volume values were calculated by the corresponding values divided by body surface area (BSA). The BSA values were derived from the height and weight by the DuBois & DuBois formula (BSA = (W^0.425^ × H^0.725^) × 0.007184)^[@CR26]^.

### RA Measurement {#Sec7}

The dimensions of the RA were measured on 4-ch SSFP images and RV 2-ch SSFP images (Fig. [2](#Fig2){ref-type="fig"}). The RA volume was measured by the area-length method and the SAX method, similar to the LA. Single plane area-length and bi-plane area length were both used to calculate the RA volume^[@CR27]^. Similar to the measurement of the LA, maximal RA volume (RAV~max~), minimal RA volume (RAV~min~), and pre-active contraction RA volume (RAV~p−ac~) were acquired at the same phases as the LA. RA phasic functions were defined the same as LA phasic function. RA total emptying fraction, RA passive emptying fraction, and RA active emptying fraction were calculated using the same formulas. Similarly, indexed dimension and volume values were also calculated for the RA.Figure 2Measuring the right atrium dimensions in a 4-chamber view and a right ventricle (RV) 2-chamber view. (**A**) longitudinal dimension and transverse dimension in the right ventricle 2-chamber view. (**B**) longitudinal dimension and transverse dimension in the 4-chamber view. Yellow lines indicate the dimensions measured.

Inter-observer and Intra-observer Variability {#Sec8}
---------------------------------------------

Subjects (20%, 24 cases) were selected randomly to test inter- and intra-observer variability. For inter-observer variability, two independent observers (WHL and KW), with more than 2 years experience and 500 cases of CMR image analysis, finished the post-processing for atrial dimensions and volumes blindly. For intra-observer variability, one observer (WHL) repeated the measurements for all parameters using the identical methods 8 weeks apart.

Statistical Analyses {#Sec9}
--------------------

Statistical analyses were performed using SPSS (version 17.0; SPSS Inc., Chicago, IL, USA) and MedCalc (MedCalc Software version 13.0; Ostend, Belgium). The Kolmogorov-Smirnov test was used to check the normal distribution of the continuous variables. Independent-sample *T* tests were used to compare the mean values between men and women. Continuous data are presented as the mean ± SD. Non-normally distributed data were converted into log (normally distributed data), and then expressed as the mean ± SD. The normal reference range was calculated as the mean ± 2 SD. Linear regression was used to analyse the relationships between cardiac parameters and age. The inter- and intra-observer variability was assessed using the Bland-Altman method. A P value of \<0.05 was considered statistically significant.

Data Availability {#Sec10}
-----------------

The datasets is available from the corresponding author on reasonable request.

Results {#Sec11}
=======

Subject Demographic Data {#Sec12}
------------------------

The demographic data of the 135 healthy volunteers are shown in the Table [1](#Tab1){ref-type="table"}. The average age in this group was 49.9 ± 17.1 years, and 49% were males.Table 1Demographic characteristics.ParametersTotal (mean ± SD)Male (mean ± SD)Female (mean ± SD)P (Male *vs*. Female)Subjects number1356669Age (years)49.9 ± 17.150.5 ± 17.249.2 ± 17.20.665Age range (years)23 to 8323 to 7723 to 83Height (cm)160.8 ± 8.9167.4 ± 7.0154.4 ± 5.0\<0.001Weight (kg)58.5 ± 9.664.3 ± 8.953.0 ± 6.6\<0.001BMI (kg/m^2^)22.6 ± 2.822.9 ± 2.922.3 ± 2.70.162BSA (m^2^)1.6 ± 0.21.7 ± 0.11.5 ± 0.1\<0.001SBP (mmHg)118.3 ± 10.7120.8 ± 9.9115.9 ± 10.80.007DBP (mmHg)78.9 ± 9.281.7 ± 9.076.2 ± 8.5\<0.001HR (bpm)72.1 ± 8.871.3 ± 9.072.9 ± 8.50.284BMI, body mass index, calculated by (weight in kg)/(height in m)^[@CR2]^; BSA, body surface area, calculated by DuBois & DuBois formula; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate.

Normal Reference Values for LA {#Sec13}
------------------------------

### LA Dimensions {#Sec14}

The normal LA dimensions and indexed values are shown in Table [2](#Tab2){ref-type="table"}. Most dimensions showed no gender differences. The anterior-posterior dimension on the 3-ch view was greater in females than in males (31.1 ± 5.5 *vs*. 28.7 ± 5.3 mm, P = 0.011). The longitudinal diameter on 4-ch was shorter in females than in males (55.2 ± 6.0 *vs*. 57.9 ± 5.7 mm, P = 0.008). However, after indexing by BSA, the indexed LA diameters in females were slightly greater than those in males (All P \< 0.001).Table 2Total and gender specific left atrial dimensions (mean ± SD, and reference range) (n = 135).ParametersTotal (n = 135)Male (n = 66)Female (n = 69)P (Male *vs*. Female)Mean ± SDLower/upper limitsMean ± SDLower/upper limitsMean ± SDLower/upper limitsLong. − 2ch\[mm\]50.1 ± 6.3(37.6, 62.6)51.2 ± 6.2(38.8, 63.7)49.1 ± 6.1(36.8, 61.3)0.046Trans. − 2ch \[mm\]42.1 ± 5.5(31.1, 53.2)42.5 ± 6.5(29.5, 55.6)41.8 ± 4.4(33.0, 50.5)0.425Long. − 3ch \[mm\]54.4 ± 6.6(41.1, 67.6)55.1 ± 6.4(42.3, 67.9)53.7 ± 6.8(40.1, 67.3)0.239AP − 3ch \[mm\]29.9 ± 5.5(18.9, 41.0)28.7 ± 5.3(18.1, 39.3)31.1 ± 5.5(20.1, 42.1)0.011Long. − 4ch \[mm\]56.5 ± 6.0(44.6, 68.5)57.9 ± 5.7(46.5, 69.3)55.2 ± 6.0(43.3, 67.1)0.008Trans. − 4ch \[mm\]41.0 ± 4.8(31.3, 50.7)41.6 ± 4.9(31.8, 51.4)40.4 ± 4.8(30.9, 49.9)0.169Indexed Long. − 2ch \[mm/m^2^\]31.5 ± 4.7(22.1, 41.0)30.0 ± 4.2(21.5, 38.5)33.0 ± 4.7(23.6, 42.4)\<0.001Indexed Trans. − 2ch \[mm/m^2^\]26.4 ± 3.7(18.9, 33.9)24.8 ± 3.8(17.2, 32.4)28.0 ± 2.9(22.1, 33.9)\<0.001Indexed Long. − 3ch \[mm/m^2^\]34.2 ± 4.8(24.5, 43.8)32.2 ± 4.1(23.9, 40.4)36.1 ± 4.7(26.7, 45.4)\<0.001Indexed AP − 3ch \[mm/m^2^\]18.8 ± 3.8(11.3, 26.3)16.7 ± 2.8(11.0, 22.3)20.8 ± 3.4(14.0, 27.7)\<0.001Indexed Long. − 4ch \[mm/m^2^\]35.5 ± 4.4(26.8, 44.2)33.8 ± 3.9(26.0, 41.7)37.0 ± 4.2(28.7, 45.4)\<0.001Indexed Trans. − 4ch \[mm/m^2^\]25.7 ± 3.5(18.8, 32.7)24.2 ± 2.8(18.6, 29.9)27.1 ± 3.5(20.2, 34.1)\<0.001Lower/upper limits calculated as mean ± 2 SD; Long., Longitudinal dimension; Trans, Transverse dimension; AP, Antero-posterior dimension; 2ch, 2-chamber view; 3ch, 3-chamber view; 4ch, 4-chamber view; Indexed dimensions are calculated by corresponding dimensions in mm divided by BSA in m^2^.

### LA Volume and Phasic Function {#Sec15}

The LA volume parameters are shown in Table [3](#Tab3){ref-type="table"}. Correlations between parameters measured by the SAX method and the bi-plane method were moderate. Compared with the SAX method, the bi-plane method underestimated the LA volumes and overestimated the phasic function (all P \< 0.001). The LA volumes in females were significantly lower than those in males, except for LAV~max~ (P = 0.119 for SAX method and 0.090 for bi-plane area-length method, all others P \< 0.05, namely 0.009 for the LAV~p−ac~ SAX method, 0.008 for the LAV~min~ SAX method, 0.004 for the LAV~p−ac~ bi-plane area-length method, 0.020 for the LAV~min~ bi-plane area-length method) (Table [4](#Tab4){ref-type="table"}). However, after indexing by BSA, most of the volume parameters were similar between genders (P = 0.668 for the indexed LAV~p−ac~ SAX method, P = 0.654 for the indexed LA~min~ SAX method, P = 0.096 for the indexed LA~max~ bi-plane area-length method, P = 0.755 for the indexed LAV~p−ac~ bi-plane area-length method, and P = 0.949 for the indexed LAV~min~ bi-plane area-length method), except for LAV~max~ by the SAX method (female *vs*. male: 43.9 ± 8.2 mL/m^2^ *vs*. 40.05 ± 8.3 mL/m^2^, P = 0.018). The LA conduit EF was greater in females than in males when measured by either the SAX method or the bi-plane method (P = 0.004 and 0.008, respectively), while there was no significant difference in booster pump EF and total LA EF (P = 0.984 for the booster pump EF by the SAX method, P = 0.372 for the booster pump EF by the bi-plane area-length method, P = 0.095 for the total EF by the bi-plane area-length method, and P = 0.654 for the total EF by the SAX method).Table 3Short axis *vs*. bi-plane area-length left atrial volume parameters in the whole group (n = 135).ParameterShort axis methodBi-plane area-length methodP (bi-plane *vs*. sax)Difference (Mean ± SE)Pearson CorrelationPMean ± SDLower/upper limitsMean ± SDLower/upper limitsLAV~max~, in ml67.6 ± 14.2(39.1, 96)61.9 ± 14.7(32.5, 91.4)\<0.001−5.6 ± 1.10.6480.000LAV~p−ac~, in ml48.9 ± 13.1(22.7, 75.1)41.5 ± 12.8(15.9,67.1)\<0.001−7.4 ± 0.90.6760.000LAV~min~, in ml30.2 ± 8.0(14.2, 46.1)25.1 ± 8.9(7.4, 42.8)\<0.001−5.1 ± 0.70.5940.000Indexed LAV~max~, in ml/m^2^42.2 ± 8.4(25.4, 59.1)38.7 ± 9.0(20.8, 56.7)\<0.001−3.5 ± 0.60.6320.000Indexed LAV~p−ac~, in ml/m^2^30.5 ± 7.6(15.4, 45.6)25.9 ± 7.6(10.7, 41.1)\<0.001−4.6 ± 0.60.6440.000Indexed LAV~min~, in ml/m^2^18.8 ± 4.5(9.8, 27.8)15.7 ± 5.4(5.0, 26.4)\<0.001−3.1 ± 0.40.5660.000Conduit EF, %28 ± 9(10, 46)33 ± 10(12, 54)\<0.0015 ± 10.5940.000Booster pump EF, %37 ± 10(18, 57)39 ± 12(16, 62)0.0452 ± 10.5630.000Total EF, %55 ± 8(40, 70)60 ± 8(43, 76)\<0.0015 ± 10.3950.000Lower/upper limits calculated as mean ± 2 SD; LAV~max~, maximal left atrial volume; LAV~p−ac~, left atrial volume prior to atrial contraction; LAV~min~, minimal left atrial volume; Indexed volumes are calculated by corresponding volume in ml divided by BSA in m^2^; Conduit EF, Conduit left atrial emptying fraction: 100% × (LAV~max~ − LAV~p−ac~)/LAV~max~; Booster pump EF, Booster pump left atrial emptying fraction: 100% × (LAV~p−ac~ − LAV~min~)/LAV~p−ac~; Total EF, total left atrial emptying fraction: 100% × (LAV~max~ − LAV~min~)/LAV~max~. Table 4Gender specific short axis and bi-plane area-length reference values of LA volume and phasic function (n = 135).ParameterShort axis methodbi-plane area-length methodMaleFemaleP (Male *vs*. Female)MaleFemaleP (Male *vs*. Female)Mean ± SDLower/upper limitsMean ± SDLower/upper limitsMean ± SDLower/upper limitsMean ± SDLower/upper limitsLAV~max~, in ml69.5 ± 14.9(39.7, 99.4)65.7 ± 13.4(39, 92.4)0.11964.1 ± 15.6(33, 95.3)59.8 ± 13.6(32.5, 87.1)0.090LAV~p−ac~, in ml51.9 ± 13.8(24.3, 79.5)46.00 ± 11.8(22.4, 69.5)0.00944.8 ± 14.4(15.9, 73.6)38.4 ± 10.2(18.0, 58.7)0.004LAV~min~, in ml32.1 ± 8.8(14.5, 49.6)28.4 ± 6.7(14.9, 41.8)0.00826.9 ± 10.1(6.8, 47.0)23.4 ± 7.2(8.9, 37.8)0.020Indexed LAV~max~, in ml/m^2^40.5 ± 8.3(23.9, 57.1)43.9 ± 8.2(27.4, 60.4)0.01837.4 ± 9.1(19.2, 55.7)40.0 ± 8.7(22.6, 57.4)0.096Indexed LAV~p−ac~, in ml/m^2^30.2 ± 7.7(14.8, 45.6)30.8 ± 7.5(15.8, 45.7)0.66826.1 ± 8.5(9.0, 43.2)25.7 ± 6.7(12.4, 39.0)0.755Indexed LAV~min~, in ml/m^2^18.6 ± 4.8(9.0, 28.2)19 ± 4.2(10.5, 27.4)0.65415.7 ± 6(3.7, 27.7)15.7 ± 4.7(6.2, 25.1)0.949Conduit EF, %26 ± 9(8, 44)30 ± 9(13, 48)0.00431 ± 10(11, 51)35 ± 10(15, 56)0.008Booster pump EF, %37 ± 10(17, 58)37 ± 10(18, 57)0.98439 ± 13(13, 66)39 ± 10(19, 59)0.372Total EF, %54 ± 8(37, 70)57 ± 6(44, 70)0.02859 ± 9(41, 76)61 ± 8(46, 76)0.095Lower/upper limits calculated as mean ± 2 SD; LAV~max~, maximal left atrial volume; LAV~p−ac~, left atrial volume prior to atrial contraction; LAV~min~, minimal left atrial volume; Indexed volumes are calculated by corresponding volume in ml divided by BSA in m^2^; Conduit EF, Conduit left atrial emptying fraction: 100% × (LAV~max~ − LAV~p−ac~)/LAV~max~; Booster pump EF, Booster pump left atrial emptying fraction: 100% × (LAV~p−ac~ − LAV~min~)/LAV~p−ac~; Total EF, total left atrial emptying fraction: 100% × (LAV~max~ − LAV~min~)/LAV~max~.

Normal Reference for RA {#Sec16}
-----------------------

### RA Dimensions {#Sec17}

The linear RA dimensions measured on the 4-ch view and RV 2-ch view are shown in Table [5](#Tab5){ref-type="table"}. The absolute RA dimensions were similar in males and females (P = 0.193 for longitudinal diameter in 2-ch, P = 0.581 for longitudinal diameter in 4-ch, and P = 0.127 for transverse diameter in 2-ch, except P \< 0.001 for the transverse dimension in 4-ch), while the indexed diameters were higher in females than in males (P \< 0.001 for the indexed longitudinal diameter in 2ch and 4ch, P = 0.020 for the indexed transverse diameter in 4ch), except for the indexed transverse diameter in 2ch, where P = 0.087).Table 5Total and gender specific right atrial dimension parameters (mean ± SD, and reference range) (n = 135).ParametersTotalMaleFemaleP (Male *vs*. Female)Mean ± SDLower/upper limitsMean ± SDLower/upper limitsMean ± SDLower/upper limitsLong. − 2ch \[mm\]51.3 ± 6.6(38.1, 64.4)52.1 ± 6.0(40.0, 64.1)50.6 ± 7.0(36.5, 64.6)0.193Trans. − 2ch \[mm\]39.6 ± 9.8(19.9, 59.2)40.9 ± 10.2(20.5, 61.4)38.3 ± 9.3(19.7, 56.9)0.127Long. − 4ch \[mm\]50.1 ± 5.7(38.7, 61.5)50.4 ± 5.8(38.9, 61.9)49.9 ± 5.7(38.4, 61.3)0.581Trans. − 4ch \[mm\]43.5 ± 5.4(32.7, 54.3)45.6 ± 4.9(35.7, 55.4)41.5 ± 5.1(31.2, 51.8)\<0.001Indexed Long. − 2ch \[mm/m2\]32.3 ± 4.6(23.0, 41.5)30.5 ± 3.9(22.7, 38.2)33.9 ± 4.7(24.5, 43.3)\<0.001Indexed Trans. − 2ch \[mm/m2\]24.9 ± 6.4(12.1, 37.6)23.9 ± 5.9(12.2, 35.7)25.8 ± 6.7(12.4, 39.2)0.087Indexed Long. − 4ch \[mm/m2\]31.5 ± 4.5(22.5, 40.5)29.5 ± 4.0(21.4, 37.5)33.5 ± 4.1(25.4, 41.6)\<0.001Indexed Trans. − 4ch \[mm/m2\]27.2 ± 3.2(20.9, 33.6)26.6 ± 2.8(20.9, 32.2)27.8 ± 3.4(21.1, 34.6)0.020Lower/upper limits calculated as mean ± 2 SD; Long., Longitudinal dimension; Trans, Transverse dimension; AP, Antero-posterior dimension; 2ch, 2-chamber view; 3ch, 3-chamber view; 4ch, 4-chamber view; Indexed dimensions are calculated by corresponding dimensions in mm divided by BSA in m^2^.

### RA Volume and Phasic Function {#Sec18}

The RA volume and phasic function data are shown in Table [6](#Tab6){ref-type="table"}. Compared with the SAX method, the absolute volume and indexed volume measured by either single plane or bi-plane area-length methods were much lower (all P \< 0.001). Correlations between the SAX and the area-length methods were moderate. The phasic functions of the RA were similar when assessed by the two methods (all P \> 0.05, namely P = 0.278 for the conduit EF by the bi-plane area-length method *vs*. the SAX method, P = 0.209 for the total EF by the bi-plane area-length method *vs*. the SAX method, P = 0.064 for the conduit EF area-length in the 4ch method *vs*. the SAX method, P = 0.073 for the booster pump EF area-length in the 4ch method *vs*. the SAX method, P = 0.369 for the total EF area-length in the 4ch method vs. the SAX method, except P = 0.002 for the booster pump EF by the bi-plane area-length method *vs*. the SAX method). The absolute RA volume was larger in males than in females (All P \< 0.001), and this difference persisted for a number of methods after indexing by BSA (P = 0.021 for indexed RAV~p−ac~ by the SAX method, P = 0.001 for indexed RAV~p−ac~ by the bi-plane area-length method, P = 0.005 for indexed RAV~min~ by the SAX method, P = 0.001 for indexed RAV~min~ by the bi-plane area-length method, P = 0.011 for indexed RAV~min~ area-length in the 4ch method, except for 0.070 for indexed RAV~p−ac~ area-length in the 4ch method), except for the RV maximal volume index (P = 0.678 for indexed RAV~max~ by the SAX method, P = 0.181 for indexed RAV~max~ by the bi-plane area-length method, and P = 0.142 for indexed RAV~max~ by the SAX method) (Table [7](#Tab7){ref-type="table"}). RA conduit EF and RA total EF were higher in females than in males by either method (for conduit EF, P = 0.003 by the SAX method, P \< 0.001 by the bi-plane area-length method, and P \< 0.001 by the area-length method in the 4-ch view; for total EF, P \< 0.001 by the SAX method, P = 0.001 by the bi-plane area-length method, and P = 0.010 by the area-length method in the 4-ch view). The RA booster pump EF showed no gender difference (P = 0.092 by SAX, P = 0.152 by bi-plane area-length, and P = 0.660 by the area-length method in the 4-ch view).Table 6Right atrial volume and phasic function parameters measured by the short axis or area-length method (n = 135).ParameterShort axis methodBi-plane area-length methodArea-length method (4-chamber)Mean ± SDLower/upper limitsMean ± SDLower/upper limitsP (sax vs. bi-plane)Difference (Mean ± SE)Pearson's CorrelationPMean ± SDLower/upper limitsP (sax vs. 4ch)Difference (Mean ± SE)Pearson's CorrelationPRAV~max~, in ml82.7 ± 19.8(43.2, 122.3)58.3 ± 18.5(21.4, 95.2)\<0.00124.1 ± 10.825\<0.00159.6 ± 18.3(22.9, 96.2)\<0.00123.4 ± 1.30.699\<0.001RAV~p−ac~, in ml61.5 ± 16.8(27.8, 95.2)43.8 ± 14.9(14, 73.6)\<0.00117.4 ± 0.90.786\<0.00145.6 ± 16.2(13.2, 78)\<0.00116 ± 1.10.704\<0.001RAV~min~, in ml40.3 ± 14.3(11.6, 69)27.5 ± 10.5(6.4, 48.6)\<0.00112.5 ± 0.80.737\<0.00128.9 ± 12.7(3.5, 54.3)\<0.00111.4 ± 10.636\<0.001Indexed RAV~max~, in ml/m251.6 ± 11.0(29.6, 73.6)36.3 ± 10.6(15.2, 57.4)\<0.00115.1 ± 0.60.797\<0.00137 ± 10.3(16.3, 57.6)\<0.00114.7 ± 0.80.631\<0.001Indexed RAV~p−ac~, in ml/m238.2 ± 9.0(20.2, 56.2)27.2 ± 8.4(10.5, 43.9)\<0.00110.8 ± 0.50.740\<0.00128.2 ± 9.2(9.9, 46.5)\<0.00110 ± 0.70.631\<0.001Indexed RAV~min~, in ml/m224.9 ± 7.7(9.5, 40.4)17.0 ± 5.9(5.2, 28.9)\<0.0017.7 ± 0.50.691\<0.00117.9 ± 7.3(3.3, 32.5)\<0.0017 ± 0.60.567\<0.001Conduit EF, %25 ± 10(4, 46)25 ± 10(4, 45)0.2780 ± 00.539\<0.00124 ± 10(3, 44)0.0640 ± 00.557\<0.001Booster pump EF, %35 ± 11(13, 56)38 ± 8(21, 55)0.0020 ± 00.2950.00137 ± 11(15, 59)0.0730 ± 00.2990.001Total EF, %52 ± 10(32, 71)53 ± 9(35, 72)0.2090 ± 00.373\<0.00152 ± 11(30, 74)0.7610 ± 00.369\<0.001Lower/upper limits calculated as mean ± 2 SD; RAV~max~, maximal right atrial volume; RAV~p−ac~, right atrial volume prior to atrial contraction; RAV~min~, minimal right atrial volume; Indexed volumes are calculated by corresponding volume in ml divided by BSA in m^2^; Conduit EF, Conduit right atrial emptying fraction: 100% × (RAV~max~ − RAV~p−ac~)/RAV~max~; Booster pump EF, Booster pump right atrial emptying fraction: 100% × (RAV~p−ac~ − RAV~min~)/RAV~p−ac~; Total EF, total right atrial emptying fraction: 100% × (RAV ~max~ − RAV~min~)/RAV~max~. Table 7Gender specific reference values of the RA volume and phasic function assessed by the short axis or area--length method (n = 135).ParameterShort axis methodBi-plane area-length methodArea-length method (4-chamber view)MaleFemaleP (Male *vs*. Female)MaleFemaleP (Male *vs*. Female)Male (n = 66)Female (n = 69)P (Male *vs*. Female)Mean ± SDLower/upper limitsMean ± SDLower/upper limitsMean ± SDLower/upper limitsMean ± SDLower/upper limitsMean ± SDLower/upper limitsMean ± SDLower/upper limitsRAV ~max~, in ml89.4 ± 21.5(46.5, 132.3)76.5 ± 15.8(44.9, 108.1)\<0.00164.6 ± 20.4(23.8, 105.3)52.5 ± 14.4(23.8, 81.2)\<0.00165.9 ± 19.1(27.6, 104.1)53.5 ± 15.4(22.7, 84.4)\<0.001RAV~p−ac~, in ml69.0 ± 18.8(31.5, 106.6)54.4 ± 10.9(32.5, 76.3)\<0.00150.8 ± 15.9(18.9, 82.6)37.3 ± 10.3(16.6, 57.9)\<0.00152.3 ± 16.4(19.4, 85.1)39.2 ± 13.2(12.8, 65.7)\<0.001RAV~min~, in ml46.4 ± 16.3(13.7, 79.1)34.5 ± 9.0(16.4, 52.6)\<0.00132.1 ± 11.6(9, 55.3)23 ± 7(9, 37)\<0.00133.6 ± 14.2(5.2, 61.9)24.5 ± 9.2(6, 42.9)\<0.001Indexed RAV ~max~, in ml/m^2^52.0 ± 12.0(28, 76)51.2 ± 10.0(31.2, 71.2)0.67837.6 ± 11.5(14.6, 60.6)35.1 ± 9.5(16, 54.1)0.18138.3 ± 10.9(16.6, 60.1)35.7 ± 9.7(16.3, 55)0.142Indexed RAV~p−ac~, in ml/m^2^40.1 ± 10.4(19.3, 60.9)36.5 ± 7.1(22.3, 50.7)0.02129.6 ± 9.2(11.2, 48)24.9 ± 6.8(11.3, 38.5)0.00130.4 ± 9.4(11.6, 49.3)26.1 ± 8.4(9.3, 43)0.07Indexed RAV~min~, in ml/m^2^26.9 ± 8.9(9, 44.8)23.1 ± 5.8(11.5, 34.8)0.00518.7 ± 6.7(5.3, 32.2)15.4 ± 4.5(6.3, 24.5)0.00119.6 ± 8.2(3.2, 36)16.3 ± 6(4.3, 28.3)0.011Conduit EF, %23 ± 9(4, 41)28 ± 11(6, 50)0.00321 ± 10(1, 42)28 ± 11(6, 50)\<0.00121 ± 9(2, 39)27 ± 10(6, 48)\<0.001Booster pump EF, %33 ± 11(11, 55)36 ± 10(15, 57)0.09237 ± 8(21, 52)39 ± 9(22, 57)0.15237 ± 11(15, 58)37 ± 11(15, 60)0.660Total EF, %49 ± 10(29, 68)54 ± 9(36, 73)\<0.00150 ± 9(32, 68)56 ± 9(38, 73)0.00149 ± 11(27, 72)54 ± 10(34, 75)0.010Lower/upper limits calculated as mean ± 2 SD; RAV~max~, maximal right atrial volume; RAV~p−ac~, right atrial volume before atrial contraction; RAV~min~, minimal right atrial volume; Indexed volumes are calculated by the corresponding volume in mL divided by BSA in m^2^; Conduit EF, Conduit right atrial emptying fraction: 100% × (RAV~max~ − RAV~p−ac~)/RAV~max~; Booster pump EF, Booster pump right atrial emptying fraction: 100% × (RAV~p−ac~ − RAV~min~)/RAV~p−ac~; Total EF, total right atrial emptying fraction: 100% × (RAV~max~ − RAV~min~)/RAV~max~.

Age Related Changes in LA and RA parameters {#Sec19}
-------------------------------------------

Correlations between age and parameters of LA or RA are shown in Table [8](#Tab8){ref-type="table"}. Age was mildly to moderately correlated with the size of the LA and RA (\|R\| from 0.074 to 0.559). Age also correlated positively with LA volume (R = 0.329, 0.518, 0.259 for LAV~max~, LAV~p−ac~, and LAV~min~, respectively, P \< 0.001, \<0.001, and =0.003, respectively), while it correlated only mildly with RA maximal volume (R = −0.220, 0.061, −0.092, and P = 0.011, 0.479, and 0.288, respectively). There was a negative correlation between age and atrial conduit EF, and a positive correlation between age and atrial booster pump EFs for both atria (All P \< 0.001); however total EFs were not correlated with age (P = 0.568 for LA and P = 0.376 for RA).Table 8Correlation between age and atrial parameters (all volume parameters were measured by the short axis method) (n = 135).ParameterCorrelation coefficientPLA Long. − 2ch \[mm\]0.337\<0.001LA Trans. − 2ch \[mm\]−0.1450.096LA Long. − 3ch \[mm\]0.559\<0.001LA AP − 3ch \[mm\]0.2070.016LA Long. − 4ch \[mm\]0.303\<0.001LA Trans. − 4ch \[mm\]0.0750.385LAV~max,~ in ml0.329\<0.001LAV~p−ac~, in ml0.518\<0.001LAV~min~, in ml0.2590.003LA Conduit EF, %−0.550\<0.001LA Booster pump EF, %0.485\<0.001LA Total EF, %0.0490.568RA Long. − 2ch \[mm\]0.2820.001RA Trans. − 2ch \[mm\]−0.501\<0.001RA Long. − 4ch \[mm\]0.1240.152RA Trans. − 4ch \[mm\]0.0740.397RAV ~max~, in ml−0.2200.011RAV~p−ac~, in ml0.0610.479RAV~min~, in ml−0.0920.288RA Conduit EF, %−0.475\<0.001RA Booster pump EF, %0.2910.001RA Total EF, %−0.0770.376Long., Longitudinal dimension; Trans, Transverse dimension; AP, Antero-posterior dimension; 2ch, 2-chamber view; 3ch, 3-chamber view; 4ch, 4-chamber LAV~max,~ maximal left atrial volume; LAV~p−ac~, left atrial volume before atrial contraction; LAV~min,~ minimal left atrial volume; LA Conduit EF, Conduit left atrial emptying fraction; LA Booster EF, Booster left atrial emptying fraction; LA Total EF, total left atrial emptying fraction. RAV~max~, maximal right atrial volume; RAV~p−ac~, right atrial volume before atrial contraction; RAV~min~, minimal right atrial volume; RA Conduit EF, Conduit right atrial emptying fraction; RA Booster EF, Booster right atrial emptying fraction; RA Total EF, total right atrial emptying fraction.

Inter- and Intra-observer Variability {#Sec20}
-------------------------------------

Inter-and intra-observer variability are shown in Tables [9](#Tab9){ref-type="table"}, [10](#Tab10){ref-type="table"}, and [11](#Tab11){ref-type="table"}. Inter- and intra-observer variabilities in atrial dimensional parameters were moderate. Compared with the SAX method, variability was lower by the area-length method in RA 4-ch view, while it was greater by the bi-plane area-length method compared with other measuring methods.Table 9Inter- and intra-variability of the atrial dimensions (n = 135).ParameterIntra-observer consistency (limits of agreement)CoVInter-observer Bias (limits of agreement)CoVLA Long. − 2ch \[mm\]0.69 (0.41, 0.85)7.110.66 (0.36, 0.84)8.74LA Trans. − 2ch \[mm\]0.67 (0.40, 0.87)8.640.62 (0.34, 0.82)11.16LA Long. − 3ch \[mm\]0.91 (0.80, 0.96)3.630.81 (0.6, 0.91)5.81LA AP − 3ch \[mm\]0.69 (0.41, 0.85)8.780.59 (0.26, 0.80)10.60LA Long. − 4ch \[mm\]0.83 (0.64, 0.92)3.820.63 (0.32, 0.82)5.62LA Trans. − 4ch \[mm\]0.84 (0.67, 0.93)5.640.71 (0.44, 0.86)7.56RA Long. − 2ch \[mm\]0.76 (0.67, 0.86)10.590.66 (0.47, 0.79)9.52RA Trans. − 2ch \[mm\]0.91 (0.80, 0.96)18.970.86 (0.71, 0.94)8.74RA Long. − 4ch \[mm\]0.78 (0.56, 0.90)5.120.59 (0.26, 0.80)7.98RA Trans. − 4ch \[mm\]0.87 (0.72, 0.94)5.520.77 (0.53, 0.89)7.59CoV, coefficient of variation. LA, left atrium; RA, right atrium; Long., Longitudinal dimension; Trans, Transverse dimension; AP, Antero-posterior dimension; 2ch, 2-chamber view; 3ch, 3-chamber view; 4ch, 4-chamber view. Table 10Inter- and intra-variability in left atrial volumes (n = 135)ParameterShort axis methodBi-plane area-length methodIntra-observer consistency (limits of agreement)CoVInter-observer Bias (limits of agreement)CoVIntra-observer consistency (limits of agreement)CoVInter-observer Bias (limits of agreement)CoVLAV~max~, in ml0.97 (0.93, 0.99)3.400.89 (0.76, 0.95)5.890.77 (0.53, 0.89)8.840.77 (0.54, 0.89)8.79LAV~p−ac~, in ml0.92 (0.83, 0.97)6.490.86 (0.7, 0.94)9.330.87 (0.72, 0.94)8.410.88 (0.75, 0.95)8.43LAV~min~, in ml0.94 (0.87, 0.97)6.180.89 (0.77, 0.95)8.650.93 (0.84, 0.97)8.680.85 (0.67, 0.93)11.71LAV~max~, maximal left atrial volume; LAV~p−ac~, left atrial volume before atrial contraction; LAV~min~, minimal left atrial volume. Table 11Inter- and intra-variability in right atrial volumes (n = 135).Parametershort axis methodBi-plane area-length methodArea-length method (4-chamber)Intra-observer consistency (limits of agreement)CoVInter-observer Bias (limits of agreement)CoVIntra-observer consistency (limits of agreement)CoVInter-observer Bias (limits of agreement)CoVIntra-observer consistency (limits of agreement)CoVInter-observer Bias (limits of agreement)CoVRAV~max~, in ml0.94 (0.87, 0.98)6.940.93 (0.84, 0.97)7.500.90 (0.78, 0.96)8.330.88 (0.75, 0.95)8.880.95 (0.88, 0.98)7.880.96 (0.91, 0.98)6.44RAV~p−ac~, in ml0.78 (0.56, 0.90)15.720.77 (0.53, 0.9)17.420.85 (0.66, 0.93)14.680.86 (0.69, 0.94)14.180.94 (0.87, 0.97)9.850.92 (0.83, 0.97)11.11RAV~min~, in ml0.86 (0.69, 0.94)15.180.84 (0.67, 0.93)16.440.82 (0.61, 0.93)20.430.76 (0.49, 0.9)22.760.89 (0.76, 0.95)18.080.84 (0.66, 0.93)21.84RAV~max,~ maximal right atrial volume; RAV~p−ac~, right atrial volume before atrial contraction; RAV~min,~ minimal right atrial volume.

Discussion {#Sec21}
==========

The present study provided comprehensive reference values for the atrial size and function by SSFP sequence in a population of healthy Chinese volunteers with a wide age range. In addition to providing normal reference standard values, we also found that the left or right atrial volume measured by area-length method was considerably lower than that produced by the SAX volume method, and gender and age have a considerable impact on atrial phasic function, especially on the conduit emptying function and booster pump function.

CMR is an accurate quantitative tool for ventricular and atrial volume and function, based on multi-slice 2D volume acquisition. The SSFP sequence has high signal-to-noise ratio, good myocardium-to-blood pool contrast, and is used routinely in a clinical setting. SSFP at 3.0T further improved the signal-to-noise contrast and could potentially have high spatial resolution to delineate thin-walled chambers. In recent years, new techniques, such as GRE shimming or short TR, have been introduced to increase the robustness of SSFP at 3.0T^[@CR28]^ and decrease banding artefacts. The normal reference values for atrial size and volume have been investigated at 1.5T in past years in a population of European descent^[@CR20],\ [@CR21],\ [@CR29]^. Only a recent study in a Singaporean Chinese population reported reference values for the left atrium volume, total left atrial ejection fraction, and right atrium area index measured by CMR at 3.0T^[@CR30]^. To the best of our knowledge, the present study is the first to investigate both left and right atrial volume and phasic function systematically.

Reference LA dimensions and volume have been studied in normal populations before. However, data derived from earlier sequences, such as TSE or GRE, are not truly comparable to SSFP sequences. Also, data acquired by SSFP sequence with prospective ECG gating not fully covering diastole are not comparable with retrospective ECG gating, which is the current routine in clinical practice^[@CR31],\ [@CR32]^. Therefore, very limited LA data could be comparable to our present study. We found the LA dimensions to be similar to those reported by Maceira, *et al*.^[@CR20]^; e.g., the upper limit for the LA antero-posterior dimension in the Chinese population was 41 mm, comparable to the 42 mm for those of European descent. The LA absolute maximal volume in our study was lower than that reported for people of European descent, but was accounted for by the BSA. However, the LA maximal volume in our study was lower than that in the Singaporean Chinese population, even after adjusting by BSA (LA maximal volume index: 50 ± 10 mL/m^2^ *vs*. 38.2 ± 10.1 mL/m^2^)^[@CR30]^. The reason for this difference is unknown, as the sequence parameters, analysis methods used, and ethnicities of the study population are similar. Left atrial phasic function is a very interesting topic in cardiovascular disease^[@CR10],\ [@CR24],\ [@CR33]^. However, few previous studies showed normal references in healthy populations. The total LAEF in our study was similar to the data presented in the study by Marceira *et al*. (60 ± 8% *vs*. 59 ± 8%)^[@CR20]^. In addition, our study demonstrated gender specific LA phasic function systemically, which was not fully explored in previous studies.

Few previous studies investigated RA size and volume. Accurate RA volume is difficult to estimate by 1D or 2D measurements. RA size, as measured by volume, was greater in males than in females, despite similar single dimension measurements in our study. Dimensions derived from the 4-ch view or RV 2-ch view were generally lower than those in previous data and the indexed dimensions were slightly higher than the indexed dimensions in people of European descent^[@CR21]^. In our study, absolute RA maximum volumes measured on short axis slices were lower than those measured in people of European descent; however, the indexed values were similar (51.6 ± 11.0 mL/m^2^; versus Sievers's 52.8 ± 16.3 mL/m^2^, and Maceira's 54 ± 10.3 mL/m^2^)^[@CR20],\ [@CR29]^. This was the first study to demonstrate the phasic function of RA in a normal population. A recent study showed that the RA emptying fraction was an independent and robust indicator for mortality in patients with pulmonary hypertension^[@CR16]^. This study suggested the potential importance of RA phasic function evaluation in future studies.

While SAX method is considered the gold standard for measuring atrial volume without geometric assumption, the area-length method is a simple alternative. Previous comparisons of these two methods based on small normal populations showed good correlation with the LA volume^[@CR34]^. Our study validated the area-length method further in a Chinese population and demonstrated that the area-length method gives a reasonable estimation of LA volume, although the absolute volume is lower than the true volume, as measured by the SAX method. Left atrial conduit function estimated by the SAX method was significantly higher than that estimated by the area-length method. Therefore, the LA volume and function derived by the area-length method should be interpreted cautiously, especially when these parameters are the main indications for the CMR examination in patients with cardiac remodelling^[@CR23]^. In contrast to the LA, area-length methods for estimating the RA volume have not been studied in depth. In our study, neither the area-length of the 4-ch nor the bi-plane area-length from 4-ch and RV 2-ch could estimate the RA volume accurately. The RA volume was underestimated remarkably by the area-length method comparing with the SAX method. Thus, if accurate RA volume measurement is necessary, the SAX method is preferred.

Generally, the absolute LA dimensions and volume were greater in males than in females; however, indexing by BSA reduced the differences. The LA maximal volume index was actually larger in females than in males. Our results were in accordance with previous studies^[@CR20],\ [@CR21],\ [@CR29],\ [@CR30],\ [@CR32],\ [@CR35]^. Right atrial size and volume were greater in males than in females, and these differences also decreased after indexing by BSA, except the RA minimal volume and RA pre-contraction volume. Phasic function was also associated with gender. Males had lower conduit empty fractions (EFs) for both atria. This phenomenon could indicate a gender difference in diastolic ventricular function. The genders have different blood pressures; therefore, whether the conduit empty function is associated with blood pressure or just gender requires further study.

The age related changes in atrial size and function were inconsistent with previous reports. In Sievers's study^[@CR32]^, LAV~max~ did not correlate with age in healthy volunteers. Maceria *et al*.^[@CR20]^ also did not find an association between the LA volume with age, and age was not an independent indicator for the LA volume. However, the LA transverse and long dimensions were related with age. In a recently reported Singaporean Chinese population, the LA maximal volume did not correlate with age in either gender^[@CR30]^. Meanwhile, another study in a large European population, including a younger age range, demonstrated a significant correlation between age and LA maximum volume^[@CR35]^. The differences among these studies might be caused by a bias in population selection, inconsistent analysis methods for the LA volume (most of these were derived by the area-length method), and limited sample size with different age groups. In our study, we correlated age with LA volume by the SAX method and our population covered a wide age range. Our study confirmed there was a moderate positive correlation between age and the LA maximal volume or LA pre-contraction volume, while the correlation between age and RA maximal volume was only slightly negative. Interestingly, we found a very significant correlation between age and the LA phasic function, which was not observed in previous studies. Both left and right atrial conduit EFs correlated negatively with age, whereas booster pump EFs correlated positively with age. These data demonstrated the impact of age on ventricular diastolic function and atrial remodelling with aging.

In summary, in the present study, we investigated the reference values of the left and right atrial dimension, volume, and phasic function using the state of art SSFP sequence at 3.0T MRI in a healthy Chinese population. The SAX method provided more accurate values for the atrial volume and showed better reproducibility compared with the area-length method, especially for the right atrial volume. Therefore, additional short axis slices for the atrium are necessary if the atrial volume is the main question in a clinical study. Indexing to BSA is important to account for certain gender differences. We also demonstrated that age is related to atrial geometry and atrial phasic function. These findings emphasized the potential utility of evaluating atrial phasic function in future studies.
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